Rallybio appoints Stephen Uden as CEO effective Aug 1; Martin Mackay becomes Executive Chairman

Rallybio Corp

Stephen Uden, current President and COO, named CEO effective Aug 1, 2023; will also join the Board.
Co-founder Martin Mackay transitions from CEO to Executive Chairman, remains full-time employee focusing on strategy and IR.
Phase 1 multiple dose cohort data for RLYB212 and initial data for RLYB116 expected in Q4 2023.
Board size increased to 11 directors; Uden appointed as Class II director with term through 2026 annual meeting.
Uden's base salary stays at $530,000, target bonus 45%; Mackay's compensation unchanged; severance terms similar.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Stephen Uden

Chief Executive Officer

RLYB · Rallybio Corp

Effective: 2023-08-01
Filed: June 29, 2023, 7:59 PM ET

On June 28, 2023, the Board of Directors (the Board) of Rallybio Corporation (Rallybio) appointed Stephen Uden, M.D., Rallybio’s President, Chief Operating Officer and Co-Founder since January 2018, to Chief Executive Officer, effective August 1, 2023.

Role change

Martin Mackay

Executive Chairman

RLYB · Rallybio Corp

Effective: 2023-08-01
Successor: Stephen Uden
Filed: June 29, 2023, 7:59 PM ET

Dr. Mackay, who has served as Chief Executive Officer and Chairman of the Board since 2018, has been appointed to Executive Chairman, effective August 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Uden was appointed as Chief Executive Officer at Rallybio Corp.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On June 28, 2023, the Board of Directors (the Board) of Rallybio Corporation (Rallybio) appointed Stephen Uden, M.D., Rallybio’s President, Chief Operating Officer and Co-Founder since January 2018, to Chief Executive Officer, effective August 1, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Martin Mackay was appointed as Executive Chairman at Rallybio Corp.

Action: appointed
Role: Executive Chairman

Exact text from the filing

Dr. Mackay, who has served as Chief Executive Officer and Chairman of the Board since 2018, has been appointed to Executive Chairman, effective August 1, 2023.

View on SEC.gov

Rallybio Corp filing history →

Source: SEC EDGAR

accession 0000950170-23-030535

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.